Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chroma Therapeutics Ltd.

www.chromatherapeutics.com

Latest From Chroma Therapeutics Ltd.

European Loan Funds F2G's Late-Stage Novel Antifungal

€24m loan from the European Investment Bank with match funding will progress Phase IIb antifungal Olorofim in invasive aspergillosis. CFO Ralf Schmid goes into details with Scrip.

Financing Commercial

The IO Switch: Making Tumor-Associated Macrophages Work In Our Favor

Emerging Company Profile: Macrophage Pharma is using novel chemistry to deliver therapies directly into tumor-associated macrophages, switching their activity from immunosuppressive to immuno-stimulatory to initiate anti-tumor immune responses.

StartUps and SMEs Companies

VC Roundup: 2016 US Investment Ends On A Down Note, But Biopharma Has Second-Best Year

Venture capital investment fell $2.1bn to $7.79bn in 2016, but it was still the second-best year of VC funding for biopharma firms since 2006. Also, Venrock and Correlation closed new health care and technology funds and 10 companies raised $126.8m.

Financing StartUps and SMEs

Deals Shaping The Medical Industry, December 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced October-November 2014.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
  • Therapeutic Areas
  • Cancer
  • Inflammation
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Chroma Therapeutics Ltd.
  • Senior Management
  • Richard Bungay, CEO
    Martin Toal, MD, CMO
  • Contact Info
  • Chroma Therapeutics Ltd.
    Phone: (44) 1235 829120
    93 Innovation Dr.
    Milton Park
    Abingdon, OX14 4RZ
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register